Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatment

The U.S.-listed shares of Immuron Ltd.

powered up 66.3% toward a one-year high in premarket trading Monday, after the Australia-based biopharmaceutical company said the U.S. Food and Administration has removed a clinical hold on the Investigational New Drug application for its diarrhea treatment. The removal of the hold allows the U.S.

powered up 66.3% toward a one-year high in premarket trading Monday, after the Australia-based biopharmaceutical company said the U.S. Food and Administration has removed a clinical hold on the Investigational New Drug application for its diarrhea treatment. The removal of the hold allows the U.S.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk | CNNThe US Food and Drug Administration issued a warning on Friday to consumers and health providers to discontinue using and discard recalled Pilot COVID-19 At-Home Tests made by SD Biosensor, Inc. over 'significant concerns' of bacterial contamination.
Source: CNN - 🏆 4. / 95 Read more »

Stock Market Crash: 'Recession is a Done Deal,' Will Destroy Profits'Recession is a done deal': A renowned market bear who called the dot-com bubble warns a deep and long downturn will destroy corporate profit margins — setting stocks up for disaster
Source: BusinessInsider - 🏆 729. / 51 Read more »